ENDO PHARMS INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ENDO PHARMS INC, and when can generic versions of ENDO PHARMS INC drugs launch?
ENDO PHARMS INC has four approved drugs.
There are thirteen US patents protecting ENDO PHARMS INC drugs.
There are eighty-one patent family members on ENDO PHARMS INC drugs in thirty-nine countries.
Summary for ENDO PHARMS INC
International Patents: | 81 |
US Patents: | 13 |
Tradenames: | 4 |
Ingredients: | 4 |
NDAs: | 4 |
Drugs and US Patents for ENDO PHARMS INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Pharms Inc | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | AB | RX | Yes | Yes | 9,107,827 | ⤷ Sign Up | ⤷ Sign Up | |||
Endo Pharms Inc | COLY-MYCIN S | colistin sulfate; hydrocortisone acetate; neomycin sulfate; thonzonium bromide | SUSPENSION/DROPS;OTIC | 050356-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Endo Pharms Inc | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | AB | RX | Yes | Yes | 8,940,714 | ⤷ Sign Up | ⤷ Sign Up | |||
Endo Pharms Inc | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | AB | RX | Yes | Yes | 9,101,549 | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ENDO PHARMS INC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Pharms Inc | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | 7,404,489 | ⤷ Sign Up |
Endo Pharms Inc | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | 9,101,540 | ⤷ Sign Up |
Endo Pharms Inc | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | 9,040,088 | ⤷ Sign Up |
Endo Pharms Inc | MEGACE ES | megestrol acetate | SUSPENSION;ORAL | 021778-001 | Jul 5, 2005 | 6,592,903 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ENDO PHARMS INC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Nasal Spray | 500 mcg/spray | ➤ Subscribe | 2017-04-28 |
➤ Subscribe | Injection | 250 mg/mL | ➤ Subscribe | 2014-06-11 |
International Patents for ENDO PHARMS INC Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Russian Federation | 2005131724 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2004080383 | ⤷ Sign Up |
Denmark | 1494649 | ⤷ Sign Up |
Serbia | 20050702 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.